Markus Puhlmann
Hoofd Techniek/Wetenschap/O&O bij PERSPECTIVE THERAPEUTICS, INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Markus Puhlmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Markus Puhlmann
Eerdere bekende functies van Markus Puhlmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 01-01-2019 | 01-01-2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2015 | 01-01-2019 |
Opleiding van Markus Puhlmann
| Ludwig-Maximilians-Universität München | Doctorate Degree |
| McDonough School of Business | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| 2 | |
| Duitsland | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Perspective Therapeutics, Inc. | |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Beurs
- Insiders
- Markus Puhlmann
- Ervaring
